未登录Cardiometabolic Parameters 3 Years After Switch to Dolutegravir/Lamivudine vs Maintenance of Tenofovir Alafenamide-Based Regimens
Batterham, Rachel; Espinosa, Nuria; Katlama, Christine; McKellar, Mehri; Scholten, Stefan; Smith, Don E.; Ait-Khaled, Mounir; George, Nisha; Wright, Jonathan; Gordon, Lori; Moodley, Riya; Wynne, Brian; van Wyk, Jean
分享
收藏Assessing the Virologic Impact of Archived Resistance in the Dolutegravir/Lamivudine 2-Drug Regimen HIV-1 Switch Study TANGO through Week 144
Wang, Ruolan; Wright, Jonathan; Saggu, Parminder; Ait-Khaled, Mounir; Moodley, Riya; Parry, Chris M.; Lutz, Thomas; Podzamczer, Daniel; Moore, Richard; Gorgolas Hernandez-Mora, Miguel; Kinder, Clifford; Wynne, Brian; van Wyk, Jean; Underwood, Mark
分享
收藏Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide-Based 3-or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Results Through Week 144 From the Phase 3, Noninferiority TANGO Randomized Trial
Osiyemi, Olayemi; De Wit, Stephane; Ajana, Faiza; Bisshop, Fiona; Portilla, Joaquin; Routy, Jean-Pierre; Wyen, Christoph; Ait-Khaled, Mounir; Leone, Peter; Pappa, Keith A.; Wang, Ruolan; Wright, Jonathan; George, Nisha; Wynne, Brian; Aboud, Michael; van Wyk, Jean; Smith, Kimberly Y.
分享
收藏Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide-Based 3-or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study
van Wyk, Jean; Ajana, Faiza; Bisshop, Fiona; De Wit, Stephane; Osiyemi, Olayemi; Sogorb, Joaquin Portilla; Routy, Jean-Pierre; Wyen, Christoph; Ait-Khaled, Mounir; Nascimento, Maria Claudia; Pappa, Keith A.; Wang, Ruolan; Wright, Jonathan; Tenorio, Allan R.; Wynne, Brian; Aboud, Michael; Gartland, Martin J.; Smith, Kimberly Y.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏